Cargando…
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
Oxidative stress and systemic inflammation are closely linked with increased risk of cancer development. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines. Glutathione S-transferases (GSTs) are enzymes involved in oxidative stress handling. Polymorphisms of genes encoding...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798955/ https://www.ncbi.nlm.nih.gov/pubmed/31681592 http://dx.doi.org/10.3389/fonc.2019.01056 |
_version_ | 1783460173956775936 |
---|---|
author | Zmorzyński, Szymon Popek-Marciniec, Sylwia Szudy-Szczyrek, Aneta Wojcierowska-Litwin, Magdalena Korszeń-Pilecka, Iwona Chocholska, Sylwia Styk, Wojciech Hus, Marek Filip, Agata A. |
author_facet | Zmorzyński, Szymon Popek-Marciniec, Sylwia Szudy-Szczyrek, Aneta Wojcierowska-Litwin, Magdalena Korszeń-Pilecka, Iwona Chocholska, Sylwia Styk, Wojciech Hus, Marek Filip, Agata A. |
author_sort | Zmorzyński, Szymon |
collection | PubMed |
description | Oxidative stress and systemic inflammation are closely linked with increased risk of cancer development. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines. Glutathione S-transferases (GSTs) are enzymes involved in oxidative stress handling. Polymorphisms of genes encoding mentioned molecules may potentially influence the risk and the outcome in neoplastic diseases. Multiple myeloma (MM) is a hematological malignancy characterized by clonal, atypical plasma cell proliferation. In the present study we investigated the association of deletion polymorphisms in GSTT1/GSTM1 genes and single nucleotide polymorphisms (SNPs) in the TNF-α gene at positions −308/−238 with the risk and outcome in MM and sensitivity to bortezomib under in vitro conditions. One hundred newly diagnosed MM patients and 100 healthy blood donors were genotyped by means of multiplex PCR (for GSTs) and PCR-RFLP (for TNF-α). In a subgroup of 50 MM patients, bone marrow cells were treated with bortezomib in vitro. Patients with −238GA+AA or GSTT1-null genotypes had 2.0 (p = 0.002) or 2.29 (p = 0.013) fold increased risk of MM. The interaction effects and risk of MM were observed in GSTT1/GSTM1-null (OR = 2.82, p = 0.018), −308/−238GA+AA (OR = 5.63, p < 0.001), as well as in all combinations of −308 with GSTs. The −308/−238GA+AA genotypes in comparison to GG were associated with earlier MM onset−61.14 vs. 66.86 years (p = 0.009) and 61.72 vs. 66.52 years (p = 0.035), respectively. Patients with GSTM1-present had shorter progression-free-survival (15.17 vs. 26.81 months, p = 0.003) and overall-survival (22.79 vs. 34.81 months, p = 0.039) compared with GSTM1-null. We did not observe relationship between response rate and studied polymorphisms. The in vitro study revealed significantly higher number of apoptotic cells at 12 nM of bortezomib in GSTT1-present, GSTM1-null/present, −308GG and −238GG/GA+AA genotypes. Our findings comprise large analysis of studied polymorphisms in MM. |
format | Online Article Text |
id | pubmed-6798955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67989552019-11-01 The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma Zmorzyński, Szymon Popek-Marciniec, Sylwia Szudy-Szczyrek, Aneta Wojcierowska-Litwin, Magdalena Korszeń-Pilecka, Iwona Chocholska, Sylwia Styk, Wojciech Hus, Marek Filip, Agata A. Front Oncol Oncology Oxidative stress and systemic inflammation are closely linked with increased risk of cancer development. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines. Glutathione S-transferases (GSTs) are enzymes involved in oxidative stress handling. Polymorphisms of genes encoding mentioned molecules may potentially influence the risk and the outcome in neoplastic diseases. Multiple myeloma (MM) is a hematological malignancy characterized by clonal, atypical plasma cell proliferation. In the present study we investigated the association of deletion polymorphisms in GSTT1/GSTM1 genes and single nucleotide polymorphisms (SNPs) in the TNF-α gene at positions −308/−238 with the risk and outcome in MM and sensitivity to bortezomib under in vitro conditions. One hundred newly diagnosed MM patients and 100 healthy blood donors were genotyped by means of multiplex PCR (for GSTs) and PCR-RFLP (for TNF-α). In a subgroup of 50 MM patients, bone marrow cells were treated with bortezomib in vitro. Patients with −238GA+AA or GSTT1-null genotypes had 2.0 (p = 0.002) or 2.29 (p = 0.013) fold increased risk of MM. The interaction effects and risk of MM were observed in GSTT1/GSTM1-null (OR = 2.82, p = 0.018), −308/−238GA+AA (OR = 5.63, p < 0.001), as well as in all combinations of −308 with GSTs. The −308/−238GA+AA genotypes in comparison to GG were associated with earlier MM onset−61.14 vs. 66.86 years (p = 0.009) and 61.72 vs. 66.52 years (p = 0.035), respectively. Patients with GSTM1-present had shorter progression-free-survival (15.17 vs. 26.81 months, p = 0.003) and overall-survival (22.79 vs. 34.81 months, p = 0.039) compared with GSTM1-null. We did not observe relationship between response rate and studied polymorphisms. The in vitro study revealed significantly higher number of apoptotic cells at 12 nM of bortezomib in GSTT1-present, GSTM1-null/present, −308GG and −238GG/GA+AA genotypes. Our findings comprise large analysis of studied polymorphisms in MM. Frontiers Media S.A. 2019-10-11 /pmc/articles/PMC6798955/ /pubmed/31681592 http://dx.doi.org/10.3389/fonc.2019.01056 Text en Copyright © 2019 Zmorzyński, Popek-Marciniec, Szudy-Szczyrek, Wojcierowska-Litwin, Korszeń-Pilecka, Chocholska, Styk, Hus and Filip. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zmorzyński, Szymon Popek-Marciniec, Sylwia Szudy-Szczyrek, Aneta Wojcierowska-Litwin, Magdalena Korszeń-Pilecka, Iwona Chocholska, Sylwia Styk, Wojciech Hus, Marek Filip, Agata A. The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title | The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title_full | The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title_fullStr | The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title_full_unstemmed | The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title_short | The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma |
title_sort | association of gstt1, gstm1, and tnf-α polymorphisms with the risk and outcome in multiple myeloma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798955/ https://www.ncbi.nlm.nih.gov/pubmed/31681592 http://dx.doi.org/10.3389/fonc.2019.01056 |
work_keys_str_mv | AT zmorzynskiszymon theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT popekmarciniecsylwia theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT szudyszczyrekaneta theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT wojcierowskalitwinmagdalena theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT korszenpileckaiwona theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT chocholskasylwia theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT stykwojciech theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT husmarek theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT filipagataa theassociationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT zmorzynskiszymon associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT popekmarciniecsylwia associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT szudyszczyrekaneta associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT wojcierowskalitwinmagdalena associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT korszenpileckaiwona associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT chocholskasylwia associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT stykwojciech associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT husmarek associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma AT filipagataa associationofgstt1gstm1andtnfapolymorphismswiththeriskandoutcomeinmultiplemyeloma |